Full Press Release Details
q2_2021xpressxre.htm EX-99.1 Document Zymeworks Reports 2021 Second Quarter Financial Results.
ZYME
Document Zymeworks Reports 2021 Second Quarter Financial Results
Key Takeaway: q2_2021xpressxre.htm EX-99.1 Document Zymeworks Reports 2021 Second Quarter Financial Results
Price reaction · baseline $31.95 (2021-08-03 close) · hit after-hours · clean, no other ZYME news in the window
day 0 close · peak
+2.1%
BiopharmaWatch Analysis
From our catalyst data and publicly available data · not financial adviceBest trade, last catalyst
+23%
120-day peak, hindsight
Typical move
5.4%
average across 7 past catalysts
Cash runway
~35 mo
Minimal dilution risk
Lead asset
ZW49
Phase 1 · HER2-expressing Cancers